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BIOMIMETIC POYPEPTIDES: 
A NEW STRATEGY FOR MUSCLE 
TISSUE REGENERATION
Antonella Bandiera, Paola Lorenzon and Paola D’Andrea   
University of Trieste, Department of Life Sciences, via L. Giorgeri 1, 34127 Trieste
Abstract — Despite recent progress in regenerative medicine, functional muscle tissue restoration still 
represent a challenge, being unable to self- restore significant tissue loss, as consequence of trauma, congenital 
defects, tumor ablation or denervation. The creation of new muscle through tissue engineering represents an 
alternative for the replacement of tissue after severe damage. Among the many materials available, those of 
natural origin are preferable for their biocompatibility and their capacity to resemble the native  physiologic 
environment of cells. A new opportunity is represented by the adoption of a biomimetic approach that allows 
to realize compounds that are in –between natural and synthetic origin with limited variability and controlled 
features. Human elastin-like polypeptides that have been designed and produced in our laboratory represent 
an innovative and promising tool to be exploited in muscle tissue engineering.
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_____________________________________________________________________ 
1 BACKGROUND
Perhaps the most appealing opportunity is represented by gaining inspiration from nature for the 
precise “tailoring” of biomaterials with finely tuned unique functional properties. The assembling of 
functional protein domains lead to the creation of new, artificial bio-inspired polypeptides. A very 
interesting and promising model is represented by Human Elastin-Like Polypeptides (HELP), the 
repetitive artificial polypeptides based on penta- or hexa- peptidic motifs that characterize elastin [1]. 
These protein polymers retain several peculiar biophysical properties as, for example, the reversible 
inverse phase transition, changing the solubility and aggregation state in response to temperature 
variation. 
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2 OBJECTIVES
We will employ HELPs biopolymers to realize biomimetic surfaces with different mechanical properties 
to favour  muscle cell culturing. The biomimetic environment is expected to enhance the applicative 
potential of the cells for skeletal muscle regeneration. Our main aim is to evaluate the capacity of HELP 
polypeptides to support cell adhesion, growth and differentiation in vitro. Particular attention will be 
dedicated to the differentiation process that lead to myotube formation, expression of an organized 
contractile apparatus and assembly of the excitation-contraction coupling apparatus. 
3 APPROACH & METHODS
General approach
We have already shown that the properties of HELPs can be exploited to prepare biomimetic surfaces. 
These surfaces are well tolerated by cells that adhere and grow, remaining viable. Their differentiation 
potential has been shown to be unaltered. HELP polypeptide in particular can be used also to realize 
three-dimensional biomimetic environments that allow viable cell encapsulation. Moreover, the 
functionality of these biopolymers can be further expanded, embedding in the same macromolecule 
a bioactive domain.
Methods
The two prototypes of recombinant HELP biopolymers, as well as a biopolymer recently synthesized 
(HEPLc), will be tested in combination with myoblast C2C12 cells. Cell viability, proliferation and 
differentiation will be studied. In particular, the myotube formation potential of C2C12 cultured on these 
elastin biomimetic subtrates will be evaluated, in conjunction with the expression of differentiation 
markers, such as myogenin and skeletal muscle myosin and components of the calcium signalling 
machinery. In the next step, the cells will be seeded and/or embedded into 3D HELP scaffolds to boost 
cell differentiation towards a fully competent contracting muscle cell. 
4 RESULTS
Skeletal muscle fibers, in vivo, derive from a highly coordinated sequence of molecular and cyotogical 
changes, ultimately leading to the expression of the contractile, multinucleated phenotype (Fig. 1). 
Figure 1. Differentiation pattern and steps for skeletal muscle fibers formation
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C2C12 myoblasts can be induced to recapitulate, in vitro, most of these steps, thus representing a 
useful model to test the suitability of new biomaterials to stimulate muscle formation.
We compared the proliferation of C2C12 myoblasts seeded onto glass coverslips in the presence and 
in the absence of three HELP biopolymers (HELP, HELP1 and HELPc). WST-1 assay showed intense 
proliferation in all conditions tested after 24, 48 and 72h in culture, and a significant (***p < 0.001 **p < 
0.01) increment of cell number on the HELP biopolymers treated glass coverslips at 48 and 72h. 
Figure 2. C2C12 myoblasts 
proliferation assessed by WST-
1 assay.
Figure 3. C2C12 myoblasts cultured on different substrates.
We assayed the ability of HELP polymers to stimulate cell alignment and fusion into myotubes. 
Cells were induced to differentiate by decreasing the serum concentration. After 48 h,  a significant 
increase of myotubes was detected in cells seeded onto HELP biopolymers, in comparison with cells 
grown onto glass coverslips (Fig.3). 
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5 POTENTIAL NEW PRODUCTS 
• Product: The HELP polypeptides have been designed to be further modified by addition of a functional, 
bioactive domain that can confer a new functionality to the whole macromolecule. These domains 
could be easily embedded in the HELP scaffold to obtain a new hybrid macromolecule from which 
functional biomaterials could be obtained under different formulations as for example hydrogels, 
coatings, microspheres, films and others. This kind of materials hold a great potential for development 
of new functional devices for cell and drug delivery. 
• Patent: 3D matrices of human elastin-like polypeptides and method of preparation thereof”, 
application No: EP2419442, Apr 15th, 2010. 
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7 CONTACT OR COLLABORATIONS NEEDED
Future collaboration with industrial partners is needed.
8 COMMUNICATION TOOLS
• Results of the work are disseminated through high quality scientific publications.
• Ciofani, G., Genchi, G.G., Liakos, I., Athanassiou, A., Mattoli, V., Bandiera, A. (2013),
• Human Recombinant Elastin-Like Protein Coatings for Muscle Cell Proliferation and Differentiation, 
Acta Biomater., 9, 5111-5121. 
• Çelebi, B., Cloutier, M., Balloni, R., Mantovani, D., Bandiera, A. (2012)
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• Human elastin- based recombinant biopolymers improved mesenchymal stem cell differentiation 
Macromol. Biosci., 12, 1546-1554. 
• Bandiera A., Sist P., Urbani R. (2010)
• Comparison of Thermal Behavior of Two Recombinantly Expressed Human Elastin-Like Polypeptides 
for Cell Culture Applications.
• Biomacromolecules, 11, 3256–3265.
9 FUNDS NEEDED
9.1 For basic research (investigation of biological mechanisms): 30.000 €  
9.2 For applied research (solutions for real-world problems): 50.000 €
10 CONCLUSION
The results presented here open a promising perspective for development of new strategies for muscle 
tissue regeneration. The biomimetic elastin polypeptides have been shown to be cytocompatible with 
myoblasts and the propensity to direct them to a more differentiated phenotype has been observed. 
These studies hold the potential to solve important unmet medical needs, as those related to muscle 
tissue restoration and regeneration.
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